Latest Stories
1 Volatile Stock to Target This Week and 2 Facing Challenges
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor confidence when the ride gets bumpy.
2 Profitable Stocks to Research Further and 1 We Ignore
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
3 Stocks Under $50 Walking a Fine Line
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
3 Russell 2000 Stocks We Approach with Caution
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
3 Growth Stocks We Steer Clear Of
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s punishment can be swift and severe when trajectories fall.
1 Russell 2000 Stock with Impressive Fundamentals and 2 Facing Headwinds
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
3 Stocks Under $10 We Steer Clear Of
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q3 Earnings?
Myriad Genetics’s 38.9% return over the past six months has outpaced the S&P 500 by 24.6%, and its stock price has climbed to $7.21 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Ford (F): Buy, Sell, or Hold Post Q3 Earnings?
Ford’s 27.1% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $13.15 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
2 Reasons to Avoid HASI and 1 Stock to Buy Instead
HA Sustainable Infrastructure Capital has had an impressive run over the past six months as its shares have beaten the S&P 500 by 14.4%. The stock now trades at $33.43, marking a 28.7% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.